|
San Francisco, CA (Jan. 12,
2010) – Biomoda President John Cousins
recently presented an update on the Biomoda diagnostic for
early-stage lung cancer at the OneMedPlace Finance Forum in San
Francisco, CA.
The
OneMedPlace Finance Forum connects emerging companies in the
healthcare and life science industries with investors and
strategic partners that can help bring new technologies to the
marketplace.
Biomoda
was invited to present at the two-day conference Jan. 12-13.
Click
this link to view video of the Biomoda presentation:
http://www.onemedplace.com/
onemedforum/company_
presentation_content.php?id=
13497
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements are based on
estimates, projections, beliefs and assumptions of Biomoda
management at the time of such statements and are not guarantees
of future performance. Forward-looking statements involve risks
and uncertainties in predicting future results and conditions.
Actual results could differ materially from those projected in
these forward-looking statements due to a variety of factors,
including, without limitation, the acceptance by customers of our
products, our ability to develop new products cost-effectively,
our ability to raise capital in the future, the development by
competitors of products using improved or alternative technology,
the retention of key employees and general economic conditions.
Forward-looking statements are made as of the date of this press
release and are subject to change without notice.
CONTACT:
Biomoda, Inc.
John
Cousins
505.821.0875
investor@biomoda.com
|
